ROCKWELL MEDICAL, INC. Proceeds from Notes Payable
ROCKWELL MEDICAL, INC. (RMTI) reported Proceeds from Notes Payable of $20.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-02-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2016-02-29
- ROCKWELL MEDICAL, INC. proceeds from notes payable for the quarter ending 2013-12-31 was $0.00.
- ROCKWELL MEDICAL, INC. proceeds from notes payable for the quarter ending 2013-09-30 was $0.00.
- ROCKWELL MEDICAL, INC. proceeds from notes payable for fiscal 2013 was $20.00M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $20.00M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $20.00M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $20.00M 10-Q · filed 2014-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |